Evogene Ltd. (EVGN)
0.5951
-0.09
(-12.87%)
USD |
NASDAQ |
Jun 02, 16:00
0.62
+0.02
(+4.18%)
After-Hours: 20:00
Evogene Total Liabilities (Quarterly) : 6.809M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Compugen Ltd. | 50.51M |
| Pluri, Inc. | 39.06M |
| Scinai Immunotherapeutics Ltd. | 3.523M |
| CollPlant Biotechnologies Ltd. | 4.297M |
| Regentis Biomaterials Ltd. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.95M |
| Shareholders Equity (Quarterly) | -2.545M |
| Debt to Equity Ratio | -0.798 |
| Current Ratio | 2.790 |
| Net Debt Paydown Yield | 1.18% |